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Microbiomic flora in digestive tract is pivotal to the state of our health and disease. Antibiotics affect GI, control composition of
microbiome, and shift equilibrium from health into disease status. Coccidiosis causes gastrointestinal inflammation. Antibiotic
additives contaminate animal products and enter food chain, consumed by humans with possible allergic, antibiotic resistance and
enigmatic side effects. Purposed study induced nonpathogenic, immunogenic organisms to protect against disease and abolish
antibiotics’ use in food animals and side effects in man. Diverse species of Coccidia were used as model. Immature organisms
were treated with serial purification procedure prior to developmental stages to obtain altered strains. Chicks received oral gavage
immunized with serial low doses of normal or altered organisms or sham treatment and were challenged with high infective
normal organisms to compare pathogenicity and immunogenicity. Mature induced altered forms of E. tenella and E. necatrix
lacked developmental stage of “sporocysts” and contained free sporozoites. In contrast, E. maxima progressed to normal forms
or did not mature at all. Animals that received altered forms were considerably protected with higher weight gain and antibody
titers against challenge infection compared to those that received normal organisms (𝑝 < 0.05). This is the first report to induce
selected protective altered organisms for possible preventive measures to minimize antibiotic use in food animals.
1. Introduction
The microbiomic flora living in the digestive tract plays a
pivotal role in the state of our health and disease. Recent
investigations have been focused on medication use specif-
ically antibiotics that affect digestive tract, which can control
the microbiome composition and shift the equilibrium from
health into disease status [1].
The recent decades are associated with the severe
increases in the prevalence of IgE-mediated [2] and non-
IgE-mediated food allergies and coincide with the rise in
the antibiotic supplementation in poultry and livestock. For
instance, the glioma development has been linked with
elevated IgE and possible food allergies. Additionally, glioma
patients have shown drastically higher rate of penicillin skin
positive test with elevated blood eosinophil counts than
the nonglioma control subjects [3]. These findings indicate
an intricate association amongst glioma progression and
possible state of combined food and antibiotic allergies in
these patients.
The increase in antibiotic resistance has created a complex
dilemma facing the public wellbeing. Indeed, the use of
antibiotics against infections has created conundrum, as high
doses may facilitate evolution of antibiotic resistance than
curing infections. On the other hand, antibiotics’ combina-
tion and extended period of treatments can promote severe
injuries [4]. Further, suboptimal dose of antibiotics use as
recently recommended may not act sufficiently enough to
eradicate the pathogens.
Meanwhile, current consumers’ awareness regarding the
antibiotics residue contamination of poultry products and
antibiotic resistant pathogenicmicrobial has caused concerns
and recommendations to minimize the use of antibiotics as
growth promoters in livestock in the USA [5] and worldwide.
Coccidiosis is a costly infectious disease which causes
morbidity as well as fatality in livestock and poultry industry.
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So far, there is no safe and protective vaccine or practical
prevention available [6]. Coccidians are host defined api-
complexan organisms which exclusively cause gastrointesti-
nal inflammatory complications and diarrhea in man and
animals. In contrast, Toxoplasma, another related member
of Apicomplexa with intraintestinal (coccidian forms) and
extraintestinal stages, is cosmopolitan and infects animals
andman as well as every single organ and cell in the body [7].
Coccidiosis is one of the major diseases related to the food
animals. Losses are directly due to morbidity as coccidiosis
results in reduction in weight gain and egg production as well
as affecting the quality of meat by decreased feed conversion,
malabsorption, and maldigestion and further leads to mor-
tality [8]. Eimeria infection predisposes animals to clostridial
infection and necrotic enteritis [9]. Common preventive
practice includes the use of subtherapeutic doses of antibiotic
additives into poultry and livestock diets which contaminate
eggs, milk, and meat production. Antibiotics enter the food
chain and are consumed by humans with possible allergic,
antibiotic resistance [10] and other yet elusive side effects.
For instance, the use of sulfonamide as anticoccidial has
encountered the emergence of drug-resistant strains [11].The
estimated annual cost of coccidiosis in broiler production
alone has been tripled ($350 million) in last decades in USA
[12, 13] mainly due to anticoccidial drugs used to control the
infection. Although continuous medication in feed has been
effective against the disease outbreak, there are several disad-
vantages including sequential development of drug resistance
and side effects in the consumers which necessitate constant
search for new and effective compounds and vaccination.
Animals that recover from the infection develop species
specific immunity induced by the exposure to organisms
or live vaccines. The viable vaccination with Coccivac, a
mixture of diverse pathogenic species of birds’ Eimeria, has
been used for over 1/2 century in the United States [14].
This live vaccine causes (1) poor feed conversion, (2) a long
duration required to evolve immunity against the disease,
(3) possibility of introducing infection, (4) and difficulties of
administering and managing the flocks. Other experimental
vaccines are the attenuated strains including serial passages of
E. tenella into chorioallantoic chick embryo [15] which were
found to be ineffective. Since their discovery over a century
ago [16], Eimeria have been described as organisms with
four encapsulated sporocysts, each containing two infectious
organisms called “sporozoites.”
Thepurpose of this studywas to introduce nonpathogenic
but immunogenic organisms to protect against the disease
and to abolish the use of antibiotics in food animals and
the side effects in the consumers. By utilizing purification
procedure, altered E. tenella and E. necatrix were provoked
to evolve 8 free sporozoites with no sporocyst formation.
As a proof of concept, these altered organisms were less
pathogenic than normal organisms but similarly immuno-
genic to normal forms. This investigation reports the forma-
tion of altered organisms to be serendipitous and to depend
on the species of the organisms while their immunogenicity
was reported to be comparable to normal organisms with use
of birds as model and to warrant future investigations.
2. Materials and Methods
2.1. Ethics. This investigationwas conducted according to the
guidelines and approved by the Institutional Biosafety and the
Institutional Animal Care and Use Committee (IACUC).
2.2. Animals. One-day-old specific pathogen-free (SPF)
inbredWhite Leghorn chicks were obtained from the Poultry
Science and kept in Coccidia-free and pathogen-free rooms,
in daily disinfected wire-floor cages, and provided feed and
water ad libitum. Each bird was tagged with a leg band for
identification and weighed prior to, during, and at the end
of the study. Weight gain/loss was calculated by subtract-
ing the initial weight before inoculation from the weight
obtained/lost following challenge and before termination of
the study.
2.3. Oocysts Preparation. Sporulated oocysts of E. tenella, E.
necatrix, and E. maxima were originally obtained from Eli
Lilly and Company (Indianapolis, IN). Fresh cultures were
prepared from the ceca or intestines of donor animals one
week after oral inoculation. The contents were homogenized
and the unsporulated organisms (oocysts) were separated
from debris by sieve and centrifuged at 400×g and sediment
added into 2.5% aqueous potassium dichromate (Sigma, St.
Louis, MO) to obtain normal sporulated oocysts. In order to
obtain altered oocysts, the homogenate containing unsporu-
lated oocysts was further cleaned in a solution of 2.5%
sodium hypochlorite and rinsed with distilled water (2x).
The homogenates were centrifuged for 10min at 400×g in a
saturated salt solution (9 : 1 v.v) and then rinsed in distilled
water. Oocysts were cultured in 2.5% aqueous potassium
dichromate solution to enhance sporulation. The organisms
were enumerated using a hemocytometer and diluted in
phosphate buffer saline (PBS) according to each experiment
before oral gavage directly into animal’s crop. Normal control
animals received sham (PBS) treatment.
2.4. Infection. At 2–6 weeks of age, the animals were inocu-
lated via crop with 240, 2400, and 24000 sporulated oocysts
of either the normal or altered strain one up to three
doses according to the experimental design with a two-
week interval. Infected birds were kept in isolation cages
in a separate room and provided with food and water ad
lib. One week after the challenge inoculation, animals were
weighed and humanely euthanatized by cervical dislocation
immediately followed by open chest and cardiac exposure.
Different organs including segments of ceca and intestines
were immediately removed and slides smears were prepared
to detect the organisms. Cecal lesions were scored from 0 to
+5 according to the severity of infection [8], briefly as follows:
0 = normal mucosa and negative cecal/intestinal
smears.
1 = no detectable pathology but organisms detected in
the smears.
2 = scattered petechia on mucosa, organisms present
on the smears, and normal cecal/intestinal contents.
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3 = focal inflammation and thickening of mucosa and
isolated hemorrhage detected in lumen.
4 = multifocal inflammation and thickening of
mucosa and extensive hemorrhage in the lumen, with
little or no fecal contents.
5 = enlarged cecum/intestine with blood or sloughed
off mucosa and moribund or dead animals.
2.5. Oocysts Sporulation. Organisms’ growth and sporulation
were determined via microscopic examination. Representa-
tive samples were examined and percentage of sporulated
oocysts determined every 4 h. Sporulation was achieved
when >90% of organisms had achieved sporulation.
2.6. Anti-Eimeria Antibody Detection by ELISA. The Enzyme
Linked Immunosorbent Assay (ELISA) was performed using
a soluble oocyst antigen of E. tenella according to [8, 17].
Blood was collected into syringe from the brachial vein from
live animals and serum separated following 5min centrifuge.
Each serum sample was heat inactivated at 56∘C for 30min
before use and diluted in twofold increments. Peroxides con-
jugated 𝛾 chain rabbit anti-chicken IgG (Cappel Laboratories,
West Chester, PA) was dispensed into each microwell coated
with 11 𝜇g of antigen and incubatedwith o-phenylenediamine
(Eastman Kodak Co, Rochester, NY). Optical densities (OD)
were documented at 490 nm on ELISA reader (DYnatech Lab
Inc., Alexandria, VA).
2.7. Pathogenicity and Immunogenicity. E. tenella organisms
were used as a model to compare the immunogenicity
and pathogenicity of normal versus altered organisms. Oral
gavage into crop with 240 and then 2400 oocysts of normal
or altered organisms with a two-week interval was per-
formed on three-week-old inbred White Leghorn chicks.
Then animals were challenged with high infective (24,000)
dose of normal E. tenella. One week after each inoculation,
6 animals per group were weighed and appearance and
health status documented.Then blood samples from brachial
vein were collected and animals humanely euthanatized by
cervical dislocation and cardiac exposure followed by tissue
specimens harvest.
2.8. Frozen Sections. Oocysts were centrifuged in 20% (W/V)
bovine serum albumin (BSA) and 15% (W/V) sucrose. The
pellets were fixed with 2 drops/mL of 25% glutaraldehyde.
They were quick-frozen in liquid nitrogen and the blocks
were sectioned at the 18 𝜇m setting on cryostat. Oocysts were
embedded with mounting agent to protect the oocysts from
shattering during the sectioning procedure.The sectionswere
stained with Haematoxylin and Eosin.
2.9. Statistical Analysis. Results are expressed as mean ±
SEM unless otherwise stated. Data were evaluated utilizing
ANOVA followed by appropriate post hoc test. Statistical
significance was set at 𝑝 < 0.05.
Table 1: Six White Leghorn birds/group were inoculated with
normal (N) or altered (A) oocysts of E. tenella and euthanatized 1
week after. Control (C) birds received sham inoculation (0). Body
weight gain/g.
Group Strain Oocyst/ Weight gain Lesion Ab titer (OD)
1 A 240 104 ± 5 1 0
2 N 240 85 ± 4 1 0
3 C 0 142 ± 8 0 0
3. Results
3.1. In Vitro Sporulation and Oocysts Description. Normal
oocysts of E. tenella began cell division and sporulation 16–
20 h in the external environment to each form of four internal
sporoblasts. After 28 h four sporocysts were matured and
the sporozoites’ development was completed in 38 h (Fig-
ures 1(a)–1(f)). In contrast, altered oocysts initiated division
approximately 12 h later than normal oocysts (28 h). Paradox-
ically, organisms started to flourish into newly formed free
sporozoites at 36 h to shape no prior sporocysts formation
and sporulationwas completed after 44 h (Figures 2(a)–2(d)),
that is, total 6 h longer than expected with normal oocysts.
Greater than 95% of processed organisms developed into the
altered form. The altered organisms were round to oval in
shape (25 to 35 𝜇m by 22.5 to 27.5𝜇m) and each contained
eight banana-shaped free sporozoites (12.5–14𝜇mby 2.5 𝜇m).
While the measurements were in consistency with those of
normal form, the exception was lack of sporocysts.
3.2. Effect of Storage on the Oocysts Lifespan. The altered
organisms when stored at 4∘C for 3 months; the free
sporozoites within the oocysts then started to degenerate
(Figure 2(e)). In contrast, normal oocysts preserved the
appearance of sporocysts and sporozoites with no visible
signs of degeneration over 1 year after storage at 4∘C. This
establishes the specific protective entity of the sporocysts
provided for the longevity and infectivity of the sporozoites.
3.3. Altered Oocysts of Other Species of Eimeria. Attempts
were made to determine whether or not parallel develop-
mental alteration would occur with other related coccidian
organisms. Similarly, the altered oocysts of E. necatrix,
another pathogenic Coccidia, were induced utilizing the
same methodology as described for E. tenella organisms.
Likewise, altered E. necatrix oocysts contained eight free
forming sporozoites and lacked sporocystic structures (Fig-
ure 2(f)). In contrast, when another species, E. maxima,
was treated with similar procedure, the organisms either did
not complete sporulation process or simply transformed into
normal sporulated oocysts (Figures 2(g) and 2(h)).
3.4. Oocysts and Immunity. In order to investigate the
immunogenicity of the organisms, the inbred animals each
were given escalating doses from low 240 (Table 1) and
then 2400 (Table 2) of normal or altered organisms ones
with a two-week interval. The animals which were treated
with altered strain all profoundly gained more weight (𝑝 <
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(d) (e) (f)
Figure 1: Normal oocysts of Eimeria tenella during in vitro growth and sporulation from 0 to 38 h (slide representative from over 100
organisms). (a) Immature organism (unsporulated oocyst) at 0 h × 1,000. (b) Normal organism start division at 16 h × 1,200. (c) Four spherical
sporoblasts and a polar granule formation visible at 20 h × 1,100. (d) Ellipsoidal sporoblasts at 24 h × 1,000. (e) Sporocysts formation at 28 h
× 1,000. (f) Sporocysts formation completed, each containing 2 mature sporozoites at 38 h × 1,000.
Table 2: Six White Leghorn birds/group were immunized with 240 followed by 2400 normal (N) or altered (A) oocysts of E. tenella with a
two-week interval (week 3). Control (C) birds that received sham inoculation (0) gained most but with no titers. Body weight gain/g and sera
antibody titer production in group A versus group N showed significant difference; ∗𝑝 < 0.05.
Group Strain Oocyst/ Weight gain Lesion Ab titer (OD)
4 A 2400 95 ± 4∗ 1 42.0∗
5 N 2400 66 ± 6 1 25.0
6 C 0 180 ± 9 0 0
0.05) and considerably showed higher antibody titers in
sera compared to those immunized with normal organisms
(𝑝 < 0.05). Two weeks after the last immunizing dose
(2400 normal or altered forms), remaining animals were
all challenged with high dose of 24,000 normal organisms
(Table 3). As a result, those animals that received only
the challenge dose (24,000 normal oocysts) drastically lost
weight (𝑝 < 0.01) and developed bloody diarrhea compared
to immunized ones. The pathological lesions were scored as
3.5 ± 0.5 with moderately severe inflamed and thickened
intestinal mucosal and hemorrhage detected in mucosa and
lumen in contrast to those immunized animals (𝑝 < 0.01,
Table 3).
All uninfected animals as expected were sera antibody
negative. Both immunized groups with either altered or nor-
mal forms showed no pathological lesions and were antibody
Gastroenterology Research and Practice 5
(a) (b) (c)
(d) (e)
(f) (g) (h)
Figure 2: (a–e) Altered organisms (oocysts of E. tenella) during evolutional stages following procedure at 28 to 44 h (slide representative
from over 100 organisms). (a) Altered organisms (oocysts) begin to divide at 28 h × 1,000. (b) Further development showing the polar granule
(indicated by arrow) at 32 h× 1,200. (c) Free sporozoites forming fromprotoplasmicmass at 36 h× 1000. (d) Sporozoites formation complete at
44 h × 1,100. (e) Degenerating altered oocyst of E. tenella 3months after storage at 4∘C × 1,070. (f–h) Eimeria necatrix and E.maxima following
the alteration procedure (slide representative from over 100 organisms). (f) E. necatrix proceeds to altered organism after the procedure to
contain free sporozoites × 1,000. (g) E. maxima fail to complete sporulation after the altering procedure. × 800. (h) E. maxima form normal
organisms containing 4 sporocysts, each with 2 sporozoites after the procedure. × 800.
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Table 3: White Leghorns were immunized with 240 and 2400 nor-
mal (N) or altered (A) oocysts of E. tenellawith a two-week interval.
Infected control group (N∧) received no previous immunization
before final challenge. Remaining birds were challenged each with
24,000 normal oocysts. Controls (C) received (0) sham inoculation.
N∧ lost weight the most and developed moderately severe lesions.
Body weight gain/g was significantly higher in uninfected animals
and those immunized with altered compared with the normal
organisms and there was weight loss in unimmunized animals. N =
6 animals/group. #𝑝 < 0.01, ∗𝑝 < 0.05. ND = not done.
Group Strain Oocyst/ Weight gain Lesion Ab titer (OD)
7 A 24,000 71 ± 4∗ 0 50.0
8 N 24,000 21 ± 4 0 38.0
9 N∧ 24,000 −50# 3.5 ± 0.5# ND
10 C 0 171 ± 4 0 0
positive with higher titers developed in those immunized
with altered compared to normal organisms. The major
difference between inoculated groups was expressed with
those animals immunized with altered organisms to gain
considerably more weight and to be in better overall health
status than those animals previously immunized with normal
organisms (Table 3, 𝑝 < 0.05).
4. Discussion
Amajor role for the vast population of intestinalmicrobiota is
to prevent incursion and colonization of infectious microbial
pathogens [1–18]. Antibiotics including the short term use
can damage propagation of the commensal microbiome to
favor susceptibility to dysbiosis. The commensal microbiota
seems to be most important when established early in life
[19]. Therefore, previous criteria such as cesarean versus
natural birth and breastfeeding may no longer be considered
as the main focal point. Therefore, the attention has been
focused on the antibiotics which can control the microbiome
composition [19] and the equilibrium between health and
disease.
Noncommunicable and inflammatory complications
such as allergic diseases affect over millions of people. The
food allergies in westernized societies have been drastically
increased mainly due to lifestyle and diet. Thus far, the
pathogenesis of allergies specifically food related allergies
has remained somehow elusive [20]. This coincides with the
upsurge in the prevalence of IgE-mediated food allergies
unsolved in children yet with possible environmental [2]
and/or nutritional exposures involvement. Additionally, a
profound relationship has been detected between the use
of macrolide antibiotics and asthma development amongst
European children (6–36 months of age) as in a multicenter
prospective trial. There was a definite correlation between
the use of macrolide in the first year of life and wheezing
in 3-year-olds, independent of the respiratory infections
[21]. Meanwhile, high prevalence of fluoroquinolone and
macrolide resistance pathogens including Campylobacter in
poultry and swine industry [22] due to misuse raises alarm
about possible overexposure and ineffectiveness of these
antibiotics in humans’ therapy.
A link between exposures to environmental factors has
been demonstrated in development of chronic inflammatory
diseases such as Crohn’s and ulcerative disease. These rev-
elations comprise childhood exposure to different dietary
elements [23]. Paradigm includes food protein induced ente-
rocolitis syndrome (FPIES) as a non-IgE-mediated hyper-
sensitivity in children that provokes symptoms of severe
vomiting, diarrhea, and acidosis a few hours following
consumption of dietary proteins, chicken, turkey, egg white,
and cow’s milk [24]. Indeed, eggs are reported as a frequent
trigger of FPIES [25]. In sporadic cases in infants, the non-
IgE-mediated hypersensitivity has been noted to shift to
typical IgE-mediated cow’s milk allergy [26]. The T cell
activation may or may not be present in FPIES [27], while
the mechanism(s) which predispose(s) one to FPIES has
remained an enigma.
Antibiotic use has a rapid andmajor effect on the luminal
bacterial community followed by long-lasting consequences
for regulation of microbial population architecture and the
host immunity [28]. Recent studies stress the mucosal-
associated commensal bacterial to formaprotective barrier to
prevent food allergic sensitization. In vivo and in vitro studies
support utilization of oral live biotherapies (e.g., prebiotics)
to modulate luminal microbiome and to induce tolerance
against food allergy in patients [28].
In a retrospective case-control trial (2004–2013), patients
with glioma (𝑛 = 913) had profoundly higher rate of peni-
cillin skin positive (IgE) test and elevated blood eosinophil
counts than matched controls (𝑛 = 1091) with a possible
link between glioma and food allergies [3]. Yet, 𝛽-lactam
antibiotics, penicillin (e.g., amoxicillin and dicloxacillin), and
cephalosporins (e.g., cefazolin and cefotaxime) are regularly
used in animals. Abuse and illegal use of these antibiotics
[29] as well as macrolides have been detected in food
animal products which can result in bacterial resistance and
allergy. For instance, tetracycline, one of the most common
antibiotics used in poultry, is deposited and remains in bones
and is passed into food chain with potential human health
risk regardless of enforced monitoring of proper withdrawal
times [30]. Diclazuril is another antimicrobial routinely used
in poultry industry to protect against coccidial infection.
We have recently reported diclazuril monotherapy or com-
bined with atovaquone to be effective against congenital
and maternal toxoplasmosis [7, 31, 32]. The combination
antibiotic therapy most effectively protected pups against
severe multiorgan inflammatory reaction and fatality and
to candidate diclazuril mono or combined therapy as an
attractive antitoxoplasmosis in humans.
The antibiotic resistant pathogens are caused by the
extensive utilization of subtherapeutic antibiotics feed to
poultry [5] and livestock. Recent consumer awareness regard-
ing the antibiotics residual contamination in poultry prod-
ucts and the antibiotic resistant pathogenic microbial has
created great concerns and recommendations to minimize
the use of antibiotics as growth promoters in livestock in
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the USA [5]. Alternative preventive measures are sought,
desirable to eliminate or minimize the use of antibiotics in
livestock and poultry industry.
In this study, the altered organisms differed from normal
oocysts in that they lacked sporocysts, even though each con-
tained eight free sporozoites.The altered organisms produced
considerably less pathogenicity in immunodeficient animals
compared to normal oocysts (unpublished data), while the
protection induced by these organisms in immunocompetent
inbred animals was no less than those induced by normal
forms. Indeed, animals inoculated with altered organisms
gained more weight and demonstrated minimal pathological
symptoms due to infection and induced higher antibody
titers compared to those that received normal forms. One
century after the original discovery of eimerians, a repro-
ducible method of altering infective forms to noninfective
ones has been introduced here. Previous studies have used
irradiation to alter the pathogenicity of the organisms [33,
34] or to induce resistance by the genetic selection of the
avian host [35]. The intramuscular injection of the plasmid
pcDNA3-1E of E. acervulina was reported to be safe in
chicken [36]. Also, E. tenella EtMic2 (a microneme protein)
displayed on the cell surface of S. cerevisiae used orally
as a live vaccine was reported to protect against challenge
infection by lowering lesion scores and fecal oocysts in
birds and stimulated humeral innate immunity [37]. Our
interrogation indicated that the process of mechanochemical
alteration in developmental stages prior to sporulation can
rationally lead to formation of altered organisms (E. tenella
and E. necatrix) with ability to immunize against severe
infections and to protect against luminal inflammation.
Normal organisms are reported to preserve internal
structure for up to 25 years in 2.5% potassium dichromate
[38]. The current study proves that sporocysts have a protec-
tive effect on preserving infectivity and longevity, as altered
organisms which lack sporocysts and their structural entity
degenerate after only 3 months. The three diverse species of
Eimeria tested in this investigation (E. tenella, E. necatrix,
and E. maxima) all did not react in a similar manner to
the altering procedure. While E. tenella and E. necatrix
both similarly followed procedure for formation of abnormal
organisms, E. maxima failed to be processed to altered
formation with no obvious explanation for this variability.
There are somediscrepancies in the life cycles of these species.
E. maxima morphologically are somewhat larger than either
of the two species. However, this may possibly have little or
no effect on the developmental behavior divergence observed
here.
Overall, this report may inform the medical community
of the vast unwanted antibiotics use and residues in ani-
mal products and a possible advancement in prevention of
coccidiosis by other approaches than the use of antibiotics,
therefore lessening the chances in consumption of antibi-
otics contaminated animal products and changes in luminal
microbiota and prevalence of the food allergies consequences
in humans.
5. Conclusion
This is the first report to induce selected protective altered
coccidian organisms for possible preventive measures to
minimize antibiotic use in food animals. The altered organ-
isms and the subsequent protective immunity they produce
against severe infection require further investigation.
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